Gilead Sciences

Rediff.com » News » Gilead Sciences

News for Gilead Sciences

News
Business
Sports

Govt to import 4.5 lakh vials of Remdesivir amid Covid spike

The government has placed orders for import of 4.5 lakh vials of antiviral drug Remdesivir with the first consignment of 75,000 vials expected to reach Indian shores on Friday, Chemicals and......

Amid rise in Covid cases, Centre prohibits exports of Remdesivir

In view of increased demand for remdesivir due to a surge in COVID-19 cases, the Centre on Sunday said the export of the antiviral injection and its Active Pharmaceutical Ingredients has been......

Cadila launches Remdesivir in India at Rs 2,800 per vial

Drug firm Zydus Cadila on Thursday said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19, in the Indian market. ......

Hetero's generic version of remdesivir to be sold @ Rs 5,400/vial

Hetero Healthcare on Wednesday said is set to deliver 20,000 vials of its antiviral drug Covifor (remdesivir) across the country for the treatment of COVID-19, at a maximum retail price of Rs 5,400......

COVID-19: Remdesivir will be available from next week

Antiviral drug Remdesivir, approved by the United States food and regulatory body for emergency use to treat the COVID-19 patients, is expected to be available by next week, the chief executive......

Sensex soars 997 points on gains in IT, banking stocks

ONGC was the top gainer in the Sensex pack, rallying over 13 per cent, followed by HCL Tech, Hero MotoCorp, NTPC, TCS, M&M, Infosys and Maruti. NSE Nifty soared 306.55 points, or 3.21 per cent, to......

3 generic HIV/AIDS drugs: Ranbaxy-Gilead pact

Drug major Ranbaxy said Tuesday it has entered into an agreement with US-headquartered Gilead Sciences to manufacture and market three new generic HIV/AIDS drugs in India and developing......

Natco challenges Gilead's patent on Tamiflu

Hyderabad-based Natco Pharma has challenged the patent for Tamiflu - a drug to treat bird flu - in the US.The company has sought the United States Food and Drug Administration (FDA)'s approval to......

Gilead to offer multiple AIDS drug licences

US-based Gilead Sciences is scouting for partners to issue multiple 'manufacturing licences' for its AIDS drug, Tenofovir, in India and 97 other countries including those in Africa, the Caribbeans......

Gilead to allow 5 Indian firms to sell hepatitis generics in 90 countries

Multinational American drug maker Gilead Sciences was set to join hands with at least five Indian generic pharmaceutical companies and allow them to manufacture and sell cheaper versions of its new......

Top doctor says Japan must keep state of emergency

'Without vaccine, Tokyo Olympics in 2021 is difficult' IMAGE: The Tokyo Games were postponed until 2021 last week as the coronavirus outbreak deepened, an unprecedented move in the 124-year......

Rediff News

Gilead Sciences

News for Gilead Sciences

Govt to import 4.5 lakh vials of Remdesivir amid Covid spike

Amid rise in Covid cases, Centre prohibits exports of Remdesivir

Cadila launches Remdesivir in India at Rs 2,800 per vial

Hetero's generic version of remdesivir to be sold @ Rs 5,400/vial

COVID-19: Remdesivir will be available from next week

Sensex soars 997 points on gains in IT, banking stocks

3 generic HIV/AIDS drugs: Ranbaxy-Gilead pact

Natco challenges Gilead's patent on Tamiflu

Gilead to offer multiple AIDS drug licences

Gilead to allow 5 Indian firms to sell hepatitis generics in 90 countries

Top doctor says Japan must keep state of emergency

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS